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ABSTRACT 
 
 
Author:  Deepak Subramanian 
Title:  The Use of Poly(vinyl alcohol)-based Hydrogels in Biomedical Applications 
Supervising Professors: Nicholas A. Peppas, Sc. D., Delia Milliron, Ph. D. 
Polymers have found increasing favor in biomedical applications due to the greater 
control that researchers can exert over their properties. Researchers have focused on the 
development of therapies using biologically compatible polymers due to their ability to limit 
potentially harmful interactions with the body. This research has led to advances in tissue 
engineering, controlled and targeted drug delivery, and other biomedical fields, with the goal of 
improving both the effectiveness and accessibility of health care. 
Poly(vinyl alcohol) (PVA) hydrogels possess several chemical properties that make them 
well suited for biomedical applications. These include inertness and stability, biocompatibility, 
and pH-responsiveness. As a result, PVA based materials have been studied for potential 
applications in areas of biomedicine such as targeted drug delivery, tissue engineering, and 
wound healing. 
This thesis examines the properties of PVA and seeks to understand how the chemical 
and physical structure affects their properties. It then examines how these properties enhance 
their utility in potential biomedical applications. Finally, it reviews the research into 
development of PVA based materials for three different biomedical applications.
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CHAPTER ONE 
Introduction 
 In the medical field today, there is growing emphasis on harnessing the power of polymers 
and other biomaterials to develop solutions that are easy to synthesize, effective in dealing with 
the issue, and do not present any other potential issues to the patient. Researchers, favoring 
treatments that are more effective and safer for the patient, are leveraging the unique properties of 
biomaterials to develop new techniques for the diagnosis and treatment of various ailments (both 
disease and injury) in the body. 
 Biomaterials are defined as materials that are engineered to interact with biological 
systems, generally for a medical purpose [1]. As strategies for combating disease and trauma have 
developed, biomaterials have generally been used for two main purposes. The first is as a 
diagnostic. Biomaterials have been used in numerous ways (such as cell and tumor imaging agents) 
to identify characteristics of different diseases and ailments [2][3], which can ultimately lead to 
the prescription of more accurate therapies to treat the ailment. This use of biomaterials is 
important from a clinical perspective because of the greater accuracy in diagnosis of the type, 
extent and locality of the ailment and, consequently, improved efficacy of prescribed treatments. 
 The second application of biomaterials is as a therapeutic. Biomaterials can be used to treat, 
augment, repair, or replace a tissue function in the body that has been compromised because of 
disease or trauma. Biomaterials are finding increasing use in treatment in several different areas, 
such as wound healing, tissue engineering, drug delivery, tissue replacement therapies (such as 
artificial joints and prosthetic limbs), and medical devices (such as pacemakers and stents) [1]. 
Biomaterials have been increasingly used in many of these applications, as researchers have begun 
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to take advantage of the unique properties of these materials to design therapeutic solutions to 
many health issues [4][5]. Using biomaterials as therapeutics is attractive because their unique 
properties can allow for more innovative therapies to be devised and used in practice; this can lead 
to the development of more effective therapies and, ultimately, better treatment of diseases and 
ailments that affect people. 
 Biomaterials used for diagnosis or therapeutic application are broadly classified as either 
natural and synthetic-based biomaterials. Natural biomaterials, as the name indicates, are materials 
that are primarily isolated from compounds found in nature [6]. These are preferred in applications 
that are particularly sensitive and require a higher degree of biocompatibility (in order to prevent 
a harmful immune response from being triggered), as well as in applications in which the material 
has an inherent benefit in enhancing treatment. Examples of these applications that have been 
explored include wound healing [6], nerve repair [6], and urology [7]. Types of natural polymers 
that have been used in biomedical applications include alginate, chitosan, gelatin, fibrin, glucan, 
hyaluronan, and silk fibroin.  
Synthetic-based biomaterials are generally synthesized in the lab rather than being obtained 
from natural sources. While these materials may not be as biocompatible as the natural-based 
biomaterials, researchers have begun investigating synthetic-based biomaterials due to their 
unique and tunable properties, which make them very versatile for biomedical applications. 
Synthetic biomaterial research has focused on two main areas - synthetic polymers and inorganic 
nanomaterials. Synthetic polymers (in contrast to the natural polymers such as alginate and 
chitosan) are generally synthesized from their component monomers in the lab through a defined 
synthetic route; as such, properties such as molecular weight, composition, and branching can be 
controlled. This allows for control over the chemical and physical properties of these synthetic 
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polymer materials, making them ideal for more specialized applications in which their properties 
can be exploited to improve the accuracy and efficacy of their function. Synthetic polymers have 
been used in applications such as 3D scaffolds for tissue engineering [8] and controlled drug 
delivery [9]. Examples of synthetic polymers that have been explored as biomaterials for these 
applications include poly(ethylene glycol) (PEG), poly(acrylic acid) (PAA), polyethylene, 
polyurethanes, and poly(D,L-lactide-co-glycolide) (PLGA). 
 Inorganic nanoparticles used in biomedical applications are generally either composed of 
metals, metal oxides, or semiconductor materials. As nanoscale materials, these inorganic 
materials have unique properties that allow the materials to either work as standalone biomaterials 
(generally in diagnostics and cellular imaging, due to their unique optical properties) or in concert 
with natural or synthetic polymer biomaterials for other applications such as controlled drug 
delivery [10]. Examples of these inorganic nanoparticle-based biomaterials include nanoscale 
organoclays, zinc oxide, and graphene oxide. 
 In this thesis, I examine the biomedical applications of poly(vinyl alcohol) (PVA), which 
is a synthetic polymer. I specifically focus on the applications of PVA-based hydrogels in wound 
dressings, tissue engineering, and controlled drug delivery. In my analysis, I examine the 
properties of these hydrogels, with special focus on the physical and chemical properties of PVA 
hydrogels that make them most useful for these three applications.  I review current research into 
developing these hydrogels for their applications. This includes research into the use of pure PVA 
hydrogels for these applications, as well as research that has focused on the development of PVA-
based composite hydrogels that incorporate other types of biomaterials (including other natural 
biomaterials, synthetic polymers, and inorganic nanoparticles) for each of these applications and 
compares the properties and use of these hydrogels with those of pure PVA hydrogels. My goal in 
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this thesis is to present a comprehensive review of research into the use of PVA-based hydrogels 
as biomaterials in these three biomedical applications and determine their suitability for these 
applications.
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CHAPTER TWO 
Background 
2.1 PVA Hydrogels 
Poly(vinyl alcohol)-based biomaterials (henceforth abbreviated as PVA) are currently 
being researched for biomedical applications due to their biocompatibility and sensitivity to 
changes in pH, as well as their ready availability and relatively simple processing. Unlike other 
delivery devices in which the monomers undergo a polymerization reaction before being 
crosslinked, PVA is available commercially, making it easier to synthesize the gels. 
Poly(vinyl alcohol) is a polymer consisting of repeat vinyl alcohol units. However, this 
polymer is not made through direct polymerization of vinyl alcohol monomer; instead, the 
monomer vinyl acetate is polymerized to form poly(vinyl acetate), and this polymer undergoes a 
saponification reaction to form PVA [11]. This results in the synthesis of a polymer with a very 
high polydispersity index; however, the molecular weight of the PVA used in creating these 
hydrogels is generally relatively constant. 
PVA hydrogels have desirable physical properties that make them ideal for biomedical 
applications. First, PVA hydrogels demonstrate good biocompatibility when implemented in vivo, 
indicating that using these hydrogels will not have any adverse effects on normal body cells when 
ingested into the body [12]. In addition, these hydrogels have physical properties such as 
microstructure, Young’s modulus, and deformation properties that are comparable to biological 
tissues, meaning that these hydrogels are ideal for tissue substitutes and other biomedical 
applications [13]. Finally, and of most importance to this study, PVA hydrogels demonstrate some 
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sensitivity to the pH of their surroundings, indicating that they can be used as stimuli-responsive 
biomaterials for controlled drug delivery [5]. Because of these desirable properties, PVA hydrogels 
are being investigated for numerous biomedical applications, including use as controlled drug 
delivery devices. 
2.2 Crosslinking of PVA Hydrogels 
PVA hydrogels can be crosslinked in a few ways: physical crosslinking, chemical 
crosslinking, and radiation-initiated crosslinking [14]. Physical crosslinking involves the 
formation of crystalline regions in the PVA solution through repeated freezing and thawing cycles; 
in this way, a tough, elastic gel can be formed. Figure 1, below, shows the process by which the 
freezing and thawing process produces a PVA hydrogel [15]. 
 
Figure 1 – Freeze-thaw cycles to produce a PVA hydrogel. This process is used to create 
a physically crosslinked PVA hydrogel without using any chemical agents. 
This technique has been used by Yokoyama et al. and Peppas et al. to produce PVA hydrogels that 
possess greater strength and elasticity than PVA gels produced at room temperature [16][17]. One 
benefit to using this procedure is that there is no risk of retaining potentially harmful reagents after 
the gel is synthesized. However, these gels do not have the same mechanical strength of gels that 
are crosslinked chemically. 
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Creating chemically crosslinked PVA gels, on the other hand, requires the use of a 
crosslinker that can react with the available hydroxyl groups present from the vinyl alcohol repeat 
unit structure. For PVA gels, the most common crosslinkers are bifunctional aldehydes such as 
glutaraldehyde (the crosslinking agent that will be used in this experiment), as they can react with 
the hydroxyl groups to form covalent acetal bonds between PVA chains, improving the mechanical 
strength of the gel [14]. This reaction requires low pH conditions (supplied by an acid catalyst), a 
quenching agent (methanol), and a solvent to proceed. Figure 2, below, shows the mechanism of 
aldehyde-based chemical crosslinking of PVA to form hydrogels [18]. 
 
Figure 2 – Chemical crosslinking of PVA to form hydrogels. This figure shows the 
mechanism through which glutaraldehyde crosslinks PVA chains together to form hydrogels. 
This technique was used by Zu et al. to create chemically crosslinked PVA hydrogels with 
applications in transdermal drug delivery of insulin, showing that this procedure can be used to 
synthesize gels capable of performing controlled drug delivery [19]. One disadvantage of this 
procedure is that some residual acid or methanol may stay trapped within the gel, which could lead 
to some possible toxic side effects. 
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2.3 PVA-based Composite Hydrogels 
In addition to the chemical and physical crosslinking of PVA chains to form PVA 
hydrogels, other materials can be incorporated into the framework to form composite hydrogels. 
Composite materials, are amalgams of two or more different materials that each retain their own 
properties. Figure 3, below, shows a schematic of a composite material [20]. 
 
Figure 3 – Schematic of composite material. The schematic in this figure shows the 
composite material as a combination of different materials in the same framework, with both 
polymer-based materials (in red and blue) and inorganic materials (gray spheres) indicated. 
Composite hydrogels are of interest because of their ability to incorporate the properties 
of each of the component materials into the framework of the hydrogel, allowing  researchers to 
take advantage of the properties of multiple types of materials to design hydrogels that can more 
effectively serve as biomaterials for different applications. These materials can both augment the 
strengths of PVA and ameliorate some of the weaknesses that PVA has as a biomaterial. As a 
result, PVA-based composite hydrogels have been studied as a way to utilize the versatility of 
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PVA while taking advantage of the unique properties of other types of biomaterials such as 
natural polymers, synthetic polymers, and inorganic nanoparticles.
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CHAPTER THREE 
Objectives 
The objectives of this thesis are to: 
1) Provide an overview of the different applications of PVA-based hydrogels (wound 
dressing, tissue engineering, and drug delivery). 
2) Identify the relevant properties of PVA-based hydrogels and analyze their 
applicability to these applications. 
3) Review the current research into applying pure PVA-based hydrogels and PVA-based 
composite hydrogels for these applications. 
This is done by analyzing each application individually and looking at the potential of 
using PVA hydrogels in each context. This is important because not all applications 
require biomaterials with the same properties, and looking at each potential application 
on its own ensures that the applicability of PVA-based materials is analyzed in the proper 
context. Ultimately, the goal of this thesis is to determine whether PVA-based hydrogels 
(either pure PVA or composite hydrogels) are suitable biomaterials for wound dressing, 
tissue engineering, and drug delivery applications.
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CHAPTER FOUR 
PVA Hydrogels in Wound Dressing Applications 
4.1 Introduction to Wound Dressing Applications 
Wound dressings help to accelerate and improve the process of wound healing; this 
includes protecting the wound from pathogens that could enter the wound and infect the source as 
well as promoting the growth and regeneration of cells to “heal” the wound. While wound 
dressings were originally used as passive supports to merely prevent infections, developments in 
wound dressing development have focused on the creation of an optimal healing environment that 
can enhance the healing process as well.  
These “functionally active” wound dressings interact with the wound (and surrounding 
skin and tissue) to promote the action of growth factors and cell regeneration, while reducing the 
negative effects of fluid buildup and potential infection. Figure 4, below, shows how a wound 
dressing system can influence the wound healing process [21]. 
 
Figure 4 – Accelerated wound healing with “functionally active” wound dressing. This figure 
shows some of the effects of using a functionally active wound dressing on the healing process. 
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Ultimately, a good wound dressing should keep a moist environment around the wound 
(since dryness slows down the growth of epithelial cells on the wound surface), prevent 
contamination by external pathogens, allow for gas exchange with the environment, reduce 
adhesiveness to skin over time (so that the dressing fits tightly to the wound soon after application 
before being easily removed after a period of time), absorb fluids produced around the wound (to 
prevent fluid buildup and its potential consequences), remain elastic, and demonstrate 
biocompatibility [22][23]. Hydrogels possess these properties and are thus well suited for use in 
wound dressings [22]. 
4.2 Useful Properties of PVA Hydrogels 
PVA hydrogels have chemical properties that allow them to perform the desired functions 
of wound dressings. As stated before, PVA hydrogels have good biocompatibility with the human 
body [12], meaning that they will not react negatively with the body. These hydrogels specifically 
do not demonstrate any significantly harmful effects on tissue, indicating that they can be used in 
wound dressings [24]. This is especially true when the gels are prepared using physical 
crosslinking techniques rather than chemical crosslinking techniques, as this avoids the use of 
chemical crosslinking agents that could be toxic to living cells [25]. 
In addition, PVA hydrogels show very high hydrophilicity, which allows them to absorb 
aqueous fluids very well; as most bodily fluids are aqueous, these hydrogels can therefore remove 
fluids from wound sites more effectively and thus prevent fluid buildup at the wound site. Fluid 
buildup is problematic because it can lead to bacterial growth at the wound site, which could lead 
to infection and a delay in wound healing [27]. PVA, as a material, has one hydroxyl group per 
repeat unit, which means that a polymer strand of sufficiently high molecular weight will have a 
large number of hydroxyl groups that can form hydrogen bonds with water [26]. A PVA hydrogel, 
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which contains many of these polymer strands, can therefore interact with water very well and 
allows water to diffuse into the hydrogel [28]. As a result, aqueous fluids can diffuse into the 
hydrogel very readily, which removes them from the wound site to a greater extent [26]. 
Finally, PVA hydrogels have the capability to resist external environmental stresses (from 
pathogens and other sources), thus protecting the wound site from further damage and infection. 
This capability is the result of the mechanical strength of PVA hydrogels. Singh et al. have shown 
that PVA hydrogels have the requisite tensile strength and burst strength to endure the frictional 
stresses of day-to-day life by absorbing the energy without breaking [27]. Additionally, PVA 
hydrogels have shown the ability to resist bacterial penetration, and therefore can protect the 
wound site from external infection (in addition to their prevention of internal infection through 
fluid removal) [27]. Both of these properties allow wound dressings prepared from PVA hydrogels 
to provide a strong wound covering that prevents outside stresses from interfering with wound 
healing. 
4.3 Uses of PVA Hydrogels in Wound Dressings 
As described earlier, hydrogels (and PVA hydrogels in particular) are ideally suited for use 
in wound dressings; therefore, it is not surprising that these materials have been the target of a lot 
of research in this area. PVA hydrogels for wound dressing applications can be categorized into 
three areas: pure PVA hydrogels, PVA hydrogels crosslinked with biological polymers, and PVA 
composite hydrogels containing embedded nanoparticles. These approaches are covered in the 
following sections. 
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4.3.1 Pure PVA Hydrogel-based Wound Dressings 
 Winter et al. demonstrated that wound healing was accelerated in the presence of a moist 
environment when compared to a dry environment [29]. Since PVA hydrogels provide this optimal 
environment for cell growth and regeneration, different groups have attempted to synthesize PVA 
hydrogels for wound dressing purposes. Oliveira et al. [30] recently synthesized PVA gels 
containing the antimicrobial agent UK propolis, and demonstrated both the desirable chemical 
properties of the PVA gel and the antimicrobial action of the UK propolis. 
 However, pure PVA hydrogels do not have all the necessary characteristics of a good 
wound dressing material. Without blending or modification, PVA hydrogels do not possess the 
elasticity or thermal stability necessary to serve as stand-alone wound dressings [31][32]; 
therefore, most research into using PVA as a wound dressing material involves combining PVA 
with other materials improve the elasticity and provide more thermal stability. 
4.3.2 PVA-Biopolymer Crosslinked Wound Dressings 
 One approach that has been researched is to crosslink PVA with natural biopolymers such 
as glucan, alginate, and hyaluronan, among others [31]. Utilizing natural biopolymers is attractive 
for a couple of reasons. First, natural biopolymers are very readily available when compared to 
other materials or synthetic polymers; this makes their preparation easier and less expensive. Also, 
natural biopolymers can be easily modified, allowing researchers to develop functional 
biopolymers with different properties. Finally, natural biopolymers (that are generally found in 
biological tissue such as human tissue) are generally very biocompatible, meaning that addition of 
these polymers would not risk triggering an immune response from the body [31]. 
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 Glucan is a water-soluble biodegradable polymer that is generally derived by fermenting 
incubated plants [31]. As a polymer, it is of interest because of its antimicrobial and antiviral 
properties, which come about due to its stimulation of macrophages in the immune system [33]. 
Blending PVA with glucan to create a crosslinked gel can allow for the creation of a wound 
dressing material with the useful properties of PVA and the antimicrobial properties of glucan. 
Huang et al. [34] synthesized a PVA/glucan blend hydrogel by adding glucan stock solution to a 
16 wt.% PVA solution (in water) at room temperature, and casting to a film with thickness 30 μm. 
Wound dressing made from this material was tested under in vitro conditions to determine the 
dressing’s properties as well as in vivo testing on Wistar rats to check for wound healing. The 
results of the in vitro experiments indicated that adding glucan increased the elasticity of the 
hydrogel (which was a drawback of pure PVA hydrogels) while maintaining the material’s 
biocompatibility and lack of skin irritation. The results of the in vivo wound healing experiments 
showed that the blend hydrogel accelerated healing (due to the release of glucan from the gel over 
time and the facilitation of fibroblast growth on the wound tissue). Ultimately, they concluded that 
a PVA/glucan blend hydrogel would improve the properties of a hydrogel when compared to a 
pure PVA hydrogel (particularly elasticity) while accelerating wound healing through the release 
of glucan over time. 
 Alginate is a salt of the natural linear polysaccharide alginic acid, which is generally 
extracted from brown marine algae such as different types of seaweed [31]. As a polymer, alginic 
acid has good wound healing properties such as improving the hemostatic, adhesion, and cell 
proliferation properties of a wound site [35], thus making it a potentially useful copolymer for 
PVA-based wound dressing materials. Kim et al. [36] synthesized a crosslinked PVA/sodium 
alginate hydrogel using the freeze-thawing method of physical crosslinking and performed both in 
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vitro testing of the hydrogel’s absorptive and mechanical properties and in vivo testing of the 
wound dressing’s healing capabilities using male SD rats. They found that adding sodium alginate 
to the hydrogels increased their elasticity and did not affect adhesion of platelets to the hydrogel 
surface, while the in vivo studies showed that the hydrogel wound dressing accelerated 
inflammatory cell growth and epithelial tissue regeneration. From these results, they concluded 
that using the freeze-thawing physical crosslinking method to produce a PVA/sodium alginate 
hydrogel allowed for the development of a material that is more elastic than a pure PVA hydrogel 
while maintaining its biocompatibility and ability to accelerate wound healing. 
 Hyaluronan (or hyaluronic acid) is a naturally occurring biodegradable polymer that is 
generally derived from the connective tissues of mammals [31]. A unique property of hyaluronan-
based materials is that they can directly interact with proteins and growth factors in tissues to 
facilitate the healing rate and tissue repair at wound sites [37], meaning that using hyaluronan-
based materials allows the material to directly contribute to the wound healing process instead of 
merely providing the optimal environment for this process to take place. Fahmy et al. [38] used a 
freeze-thawing process to physically crosslink PVA and hyaluronan chains, creating a 
PVA/hyaluronan blend hydrogel. They performed in vitro mechanical strength, absorptivity, and 
biocompatibility testing to determine the properties of the synthesized hydrogel, as well as in vivo 
antimicrobial testing to determine the effect of adding the hyaluronan on the antimicrobial 
properties of the hydrogel. They found from the in vitro testing that adding hyaluronan increased 
the mechanical flexibility and water absorptivity of the hydrogels (when compared to pure PVA 
hydrogels) while maintaining biocompatibility at lower levels of hyaluronan. From the in vivo 
testing, they found that increasing the amount of hyaluronan provided better resistance against the 
growth of Candida albicans (one of the most common microbes in wound infections), thus 
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demonstrating its antimicrobial capabilities. They concluded that the physically crosslinked 
PVA/hyaluronan blend hydrogel demonstrates better wound dressing properties than a pure PVA 
hydrogel, while also providing the benefit of antimicrobial actions towards microbes that 
commonly infect wound sites. 
4.3.3 PVA-Nanoparticle Composite Wound Dressings 
 Inorganic nanoparticles and fibers have also been used to create composite gels with PVA 
hydrogels to improve their properties [31]. These particles enhance the mechanical and thermal 
stability of these hydrogels, especially in the area of most stress. However, since these materials 
are not biodegradable, the wound dressings are normally used for superficial and shallow wounds. 
Three common types of inorganic nanoparticles that are introduced to PVA hydrogels are clays, 
metal oxides, and carbon-based materials. 
 Nanoscale organoclays are of particular interest because of their intercalation properties in 
polymeric matrices and their nanoscale basal space, meaning that they can be incorporated into the 
PVA hydrogel matrix and serve as reinforcing agents [22]. They can also be biofunctionalized to 
improve gas transfer and antimicrobial activity [31]. Gonzalez et al. [39] synthesized PVA 
hydrogels that contain bentonite nanoparticles and tested their water absorption, water vapor 
transmission rate (a method of measuring gas transfer into and out of the wound dressing), and 
antimicrobial properties. They found that incorporating the bentonite nanoparticles improved the 
strength of the composite hydrogel, as well as providing a water vapor transmission rate that is 
similar to that of healthy skin. They demonstrated sensitivity and antimicrobial activity for L. 
monocytogenes bacteria and concluded that incorporating bentonite organoclay nanoparticles into 
the PVA hydrogel matrix led to an improvement of the mechanical, gas transfer, and antimicrobial 
properties of the hydrogel. 
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 Another approach is to incorporate metal oxide nanoparticles such as zinc oxide (ZnO) into 
the PVA hydrogel matrix. ZnO nanoparticles are of interest for PVA hydrogels because they can 
improve the mechanical and thermal stability and provide antimicrobial properties for the hydrogel 
[31]. This would improve the suitability of PVA hydrogels as wound dressings. Chaturvedi et al. 
[40] used freeze-thawing physical crosslinking methods to synthesize PVA cryogels, incorporated 
ZnO nanoparticles to create a cryogel composite, and tested the cryogel’s mechanical properties, 
biological fluid absorption, and antibacterial properties. They found that the composite cryogel 
had sufficient tensile strength for wound dressing applications as well as increased elasticity. They 
also found that the cryogel was able to absorb a large quantity of biological fluid, making it good 
for absorbing excess fluid at the wound site. The composite cryogel also demonstrated greater 
antibacterial activity due to the action of the nanoscale ZnO. They concluded that incorporating 
ZnO nanoparticles to create a physically crosslinked PVA composite cryogel allowed them to 
create a material that is more well suited for wound dressing applications. 
 Another approach that’s been attempted is to incorporate carbon-based nanoscale materials 
such as graphene oxide into PVA-based hydrogels, in order to utilize the antimicrobial properties 
of graphene oxide in addition to the useful properties of PVA hydrogels [31]. Graphene oxide also 
has good mechanical strength and can be used to reinforce PVA hydrogels in wound dressings. 
Carbon-based nanoscale materials therefore would improve the applicability of PVA composite 
hydrogels in wound dressings. Shi et al. [41] used freeze-thawing physical crosslinking methods 
to synthesize PVA/graphene oxide composite hydrogels and used γ-irradiation to reduce graphene 
oxide into graphene. They found that adding graphene oxide to the PVA hydrogel improved the 
mechanical properties (while also reducing crystallinity, which improved the flexibility of the 
material), while also improving the thermal stability of the hydrogel. They concluded that adding 
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graphene oxide improved the mechanical and thermal properties of a PVA-based composite 
hydrogel. Usman et al. [42] have showed that adding graphene oxide to PVA-based composite 
hydrogels also improved their antimicrobial properties.
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CHAPTER FIVE 
PVA Hydrogels in Tissue Engineering Applications 
5.1 Introduction to Tissue Engineering  
 Tissue engineering is a broad field that generally focuses on using biomaterials and cells 
from the body to enhance tissue growth and regeneration [43]. This typically involves using a 3D 
porous scaffold (seeded with cells and growth factors) to stimulate cell growth and serve as a 
template for tissue regeneration. Figure 5 shows a schematic that illustrates the necessary 
components for a tissue engineering system [43]. 
 
Figure 5 – Necessary components of tissue engineering. This figure shows the three main 
components – scaffold, cells, and growth factors – required for successful tissue engineering. 
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 The major application of biomaterials in tissue engineering lies in the choice of scaffold, 
as other factors are largely tissue-dependent. A good scaffold for tissue engineering should exhibit 
biocompatibility (so that it does not interact harmfully with the body and provoke an immune 
response). It should also be biodegradable (because the goal of the scaffold is to promote tissue 
regeneration rather than tissue replacement, and so the scaffold should degrade over time as the 
new cells grow and the tissue regenerates). It should also have the required mechanical strength 
and properties for the particular tissue application (which is especially important and challenging 
for bone and cartilage tissue engineering), while containing a porous scaffold architecture (so that 
cells can penetrate and diffuse through the scaffold, and allow waste products and byproducts to 
diffuse out of the scaffold and into the excretory system) [43]. Hydrogels (due to their porosity 
and good biocompatibility) have been explored as potential options for scaffolds in tissue 
engineering. 
5.2 Useful Properties of PVA Hydrogels 
 PVA hydrogels have chemical and physical properties that make them suitable for tissue 
engineering applications. First, PVA hydrogels show good biocompatibility with the human body 
[12], and therefore can be used in biomedical applications without presenting an immune response. 
As indicated before, this biocompatibility is enhanced when the gels are prepared using physical 
crosslinking techniques rather than chemical crosslinking techniques, due to the lack of potentially 
toxic crosslinking agents [25]. 
 In addition, PVA hydrogels can demonstrate good biodegradability in the presence of some 
special enzymes, due to the hydroxyl groups in the monomer structure and ester groups in the 
polymer structure. These ester linkages can be broken via the hydrolysis mechanism in synthetic 
polymers (such as PVA), thus making them easy to degrade over time; the rate of degradation can 
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be controlled by controlling the structure of the polymer [44]. The byproducts of PVA hydrogel 
degradation generally maintain the biocompatibility of the hydrogel, meaning that this degradation 
process does not produce any toxic by-products that could be harmful to the body [45]. Thus, PVA 
can be used as a promoter for tissue regeneration without having to serve as a permanent tissue 
replacement. 
 PVA hydrogels also have good mechanical strength, comparable to that of tissue [46]; 
therefore, these materials can be used in tissue engineering applications, as they can withstand the 
stresses and strains that normal tissues face without failure. Having comparable mechanical 
strength is extremely important because failure under normal physiological conditions could end 
up stunting tissue growth and regeneration rather than enhancing it. Finally, PVA hydrogels can 
be synthesized with good porosity using physical freeze-drying methods [47], indicating that these 
hydrogels can allow for tissue growth without the issue of excess material build-up at the growth 
site. Ultimately, these four characteristics of PVA hydrogels allow the material to serve as a good 
tissue engineering scaffold for various applications.  
5.3 Current Uses of PVA Hydrogels in Tissue Engineering 
 Just as with wound dressing applications, PVA hydrogels have been used in a variety of 
different ways in tissue engineering applications. To enhance the properties of PVA hydrogels, 
researchers have explored different combinations of PVA with other natural and synthetic 
materials (in addition to pure PVA hydrogels) to see how the addition of these materials affects 
the properties of the hydrogel [48]. This section details the ways that pure PVA hydrogels, PVA-
natural polymer composite hydrogels, and PVA-synthetic polymer composite hydrogels have been 
used in different tissue engineering applications.  
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5.3.1 Pure PVA Hydrogels in Tissue Engineering 
 Pure PVA hydrogels have been synthesized using a couple of different techniques, and 
these hydrogels were shown to possess optimal properties for tissue engineering applications. 
Researchers have used physical cross-linking techniques to synthesize the hydrogels and found 
that their mechanical properties were on par with those of healthy tissue (in addition to the 
necessary biocompatibility and cell adhesion for tissue engineering applications).  
For example, Jiang et al. [46] synthesized pure PVA hydrogels using a system of freeze-
thawing (FT) cycles and found that the synthesized hydrogels showed similar microstructure and 
mechanical properties to healthy tissues. This indicates that the material has good tissue-mimetic 
properties that would allow it to withstand some of the pressures from day-to-day life. In addition, 
Gupta et al. [49] demonstrated that mechanically strong freeze-thawed PVA hydrogels exhibit 
good cell adhesion and promote the growth of human fibroblast cells, indicating that these 
hydrogels can be used to promote cell growth and tissue regeneration. 
 To improve the properties of PVA hydrogels, some researchers have chemically modified 
the structure of the hydrogel using different techniques. For example, Luo et al. [50] used highly 
concentrated aqueous solutions of CO2 to partially hydrolyze PVA hydrogels and create a highly 
porous hydrogel structure. This structure enhances the hydrogel’s ability to allow cell diffusion 
into and out of the hydrogel, as well as extracellular products and necessary fluids such as water 
and air.  
The hydrogels were also exposed to human fibroblast cells, and they demonstrated the 
ability to promote cell growth, indicating that they have promise in tissue engineering applications. 
In addition, Curley et al. [51] used FT methods to prepare a salt-modified PVA hydrogel, which 
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demonstrated superior thermal stability and mechanical strength when compared to pure PVA 
hydrogels. 
 While these hydrogels show some ability to serve as good scaffolds in tissue engineering 
applications, they do not have optimal properties for tissue engineering. To improve the properties 
of these hydrogels, researchers have investigated composite hydrogels containing natural polymers 
or synthetic polymers in addition to PVA. 
5.3.2 PVA-Natural Polymer Composite Hydrogels in Tissue Engineering 
 As explained in the previous chapter, natural polymers have a number of useful properties 
that allow them to complement PVA in composite hydrogels. They are more readily available than 
other materials, are easily modified, and do not introduce potential cytotoxicity concerns to the 
hydrogel system (as the materials are naturally occurring and biocompatible) [31]; thus, they are 
good candidates for tissue engineering applications. Researchers have taken advantage of these 
properties, and many types of PVA-natural polymer composite hydrogels have been synthesized 
and studied for tissue engineering applications. This section will focus on composites with 
alginate, chitosan, and fibrin. 
 As mentioned before, alginate is a natural polysaccharide that is extracted from brown 
algae [48]. Due to its biocompatibility, ability to gel under mild conditions, and good cell adhesion 
properties, alginate is a popular choice for creating a composite hydrogel with PVA. This 
composite hydrogel may be used for craniofacial tissue regeneration as a superior alternative to 
autologous tissues or porous polyethylene (due to its mechanical properties and biocompatibility) 
[48]. Bichara et al. [52] synthesized PVA-alginate composite hydrogels and evaluated their effect 
on the growth of chondrocyte cells. They found that adding alginate to the hydrogel structure 
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significantly improved the hydrogel’s compressive strength and facilitated the growth of the 
chondrocyte cells. In addition, Stone et al. [53] prepared 1/1 PVA/alginate hydrogels using citric 
acid in situ crosslinking and demonstrated that the hydrogel’s thermal stability and mechanical 
performance did not decay over time and exposure to water, indicating that the hydrogels had the 
ability to withstand in vivo stresses. Overall, PVA-alginate composite hydrogels have shown the 
ability to perform both mechanically and biologically, meaning that they would be suitable for 
tissue engineering applications. 
 Chitosan is a derivative of the common linear polysaccharide chitin and has been 
commonly used in other biomedical applications such as wound dressings [48]. Due to its 
biocompatibility and elasticity, chitosan has been studied as a potential additive to PVA hydrogels 
to enhance their properties. Gomez et al. [54] used epichlorohydrin to crosslink PVA-chitosan 
composite hydrogels and tested their properties in biocompatibility and cell growth promotion. 
They found that these crosslinked composite hydrogels enhanced the growth of chondrocyte cells 
and formation of neotissue that exhibited similar characteristics to elastic cartilage, making it a 
potential scaffold for cartilage tissue regeneration. In addition, the gels demonstrated high 
biocompatibility and cell viability. Pandele et al. [55] used graphene oxide to prepare PVA-
chitosan composite hydrogels and tested their mechanical and biological properties. They found 
that the composite hydrogel showed significantly improved mechanical strength (particularly 
elastic modulus) and allowed proliferation of osteoblastic cells, indicating its potential application 
in bone tissue regeneration. Overall, PVA-chitosan composite hydrogels have shown the necessary 
mechanical properties and cell proliferation enhancement to serve as promising scaffolds for tissue 
engineering applications. 
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 Fibrin is another natural biomaterial that has recently been adapted for tissue engineering 
applications. It is a biodegradable polymer and can generally be isolated from a patient’s blood 
[48]. Fibrin itself is manufactured by the body during the wound healing process [56], and as such 
fibrin-based materials exhibit exceptional biocompatibility (due to the material being synthesized 
in the patient itself) and cell adhesion (as platelets need to bind to the fibrin during the normal 
wound healing process). In addition, fibrin gels have very high porosity and good mechanical 
strength, making them ideal additives to PVA hydrogels [56]. Bichara et al. [57] used PVA-fibrin 
composite hydrogels as a biosynthetic cartilage scaffold for tissue engineering. They demonstrated 
that this material showed enhanced cell adhesion and allowed cell growth in the material’s pores; 
in addition, the mechanical properties of the hydrogel were consistent with healthy cartilage (and 
were actually enhanced by cell growth in the material). Based on these results, PVA-fibrin 
composite hydrogels show promise as scaffolds in cartilage tissue engineering applications.  
5.3.3 Synthetic PVA Composite Hydrogels in Tissue Engineering 
 In addition to using natural polymers in composite hydrogels, some researchers have 
synthesized composite hydrogels using synthetic polymers [48]. While these polymers are not as 
widespread as natural polymers, and do not always exhibit the same biocompatibility as natural 
polymers, they possess very tunable physical and chemical properties that allow for increased 
customization of the composite hydrogel [48]. There have been a number of different composites 
that have been synthesized and studied; this paper will focus on composite hydrogels of PVA with 
ultra-high molecular weight polyethylene (UHMWPE), polyurethanes, and poly(D,L-lactide-co-
glycolide) (PLGA). 
 Ultra-high molecular weight polyethylene (UHMWPE) is a synthetic polymer that exhibits 
hydrophobic behavior [48]. It has previously been used in orthopedic biomedical devices such as 
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artificial joints due to its low friction coefficient and has been explored as a tissue engineering 
scaffold for orthopedic tissue regeneration [58].  
Holloway et al. [59][60] synthesized two types of PVA-UHMWPE composite hydrogels 
and examined their chemical and mechanical properties when in contact with orthopedic tissue. 
They used a grafting technique to synthesize UHMWPE fiber-reinforced PVA hydrogels and 
found that the grafted hydrogels demonstrated superior interfacial adhesion and shear strength 
[59]. They also incorporated polypropylene (PP) fibers to reinforce PVA-UHMWPE composite 
hydrogels and found that this material had material properties that closely resembled those of the 
meniscus, indicating that this material could be used as a temporary meniscus replacement during 
tissue growth [60]. 
 Polyurethanes (PU) are a class of polymers that are characterized by the presence of 
carbamate bonds between the monomer chains [48]. Due to their good biocompatibility, relatively 
easy chemical modification, and susceptibility to hydrolytic degradation, these materials have been 
explored as potential scaffolds for tissue engineering [61]. Bonadkar et al. [62] synthesized PVA-
PU crosslinked hydrogels and examined their mechanical and biological properties. They found 
that the swelling ratio and elastic behavior of these hydrogels closely mirrored that of natural 
cartilage, while chondrocyte cell viability and expression was enhanced in the crosslinked 
hydrogel [62]. This indicates that PVA-PU composite hydrogels have potential as scaffolds for 
cartilage tissue engineering applications. 
 Poly(D,L-lactide-co-glycolide) (PLGA) is a copolymer of lactic acid and glycolic acid in 
which the two monomer subunits are joined by ester linkages [48]. The hydrolytic degradation rate 
of this polymer can be controlled by adjusting the concentration of monomers in the polymer, 
while the polymer also maintains the properties of its component monomers; this makes it an 
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attractive scaffold for bone tissue engineering [63]. Nie et al. [64] prepared PVA-PLGA composite 
hydrogels containing different growth factors and observed their capacity to promote cell growth. 
They found that using the composite hydrogel enhanced chondrocyte cell adhesion and 
proliferation, as well as having sufficient porosity to allow delivery of the growth factors to the 
growing tissue [64]. These results indicate that PVA-PLGA composite hydrogels can serve as good 
scaffolds for tissue regeneration.
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CHAPTER SIX 
PVA Hydrogels in Drug Delivery Applications 
6.1 Drug Delivery and Controlled Release Systems 
 Drug delivery research involves investigating strategies to safely deliver drugs inside the 
body in a controlled and/or targeted manner. Oral drug delivery (in which an encapsulated drug is 
ingested orally and allowed to diffuse into the bloodstream via the digestive system) and 
intravenous drug delivery (in which the drug is directly injected into the bloodstream) are used to 
deliver a variety of therapeutic drugs into the body, such as insulin for diabetic patients and 
chemotherapeutics in order to treat different types of cancers. 
 One of the most significant issues with the field of therapeutic delivery today involves the 
inability to control the level of a drug in the bloodstream. With oral or intravenous delivery 
currently, the initial concentration of the drug in the bloodstream is very high (potentially toxic), 
and the concentration decreases rapidly over time due to metabolism of the drug by the human 
body. The concentration eventually reaches a level in which the drug is no longer effective, in 
providing the intended therapeutic benefit. The range of drug concentration in the bloodstream 
between the effectiveness level at the low end and the toxic level at the high end is referred to as 
the therapeutic window, and the issue with conventional drug delivery techniques is that the drug 
concentrations are too often outside the therapeutic window, and therefore the drug cannot 
effectively treat the disease [65]. 
 One method of improving the drug delivery process is controlled drug delivery, in which 
the drug transport is delayed or controlled by the use of a polymeric carrier. This carrier creates 
conditions of slower release because of molecular (drug) diffusion via the pores or microviods of 
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the polymer. In a special case of drug delivery commonly known as “intelligent drug delivery”, 
the release of the drug into the bloodstream is triggered and controlled by various physiological 
stimuli. Currently, research is being conducted into developing delivery devices (generally in the 
form of nanoparticles that encapsulate the drug) that can respond to temperature changes, pH 
changes, and the presence of an oscillating magnetic field [66][67]. In the presence of the stimulus, 
the particles undergo a structural change that causes pores in the nanoparticle to expand. As these 
pores become larger, the drug can diffuse out of the nanoparticle in larger quantities and enter the 
bloodstream. When the stimulus is removed, the pores in the nanoparticle shrink, preventing 
additional drug diffusion from taking place. It is thus possible to control the amount of drug in the 
bloodstream at any point in time by controlling the stimulus that opens or closes the pores in the 
nanoparticle shell that the drug is encapsulated within. 
Controlled drug delivery systems such as the one described above are generally composed 
of stimuli-responsive materials that can change structure when exposed to a specific type of 
stimulus. These materials are generally polymers (due to their unusual stimuli-responsive nature 
and tunability), and are synthesized either in the nanoparticle form or as gels. Synthesis generally 
involves creating a mesh-like structure by “crosslinking” the monomers together using a 
crosslinking agent. Figure 6, below, shows the crosslinking [68] in a stimuli-responsive material. 
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Figure 6 – Crosslinked hydrogel for drug delivery. In this figure, different monomer chains 
(shown in blue) are crosslinked together using a crosslinking agent. This creates a “mesh-like” 
porous structure that encapsulates the drugs to be loaded and released from the polymer. 
 In addition to the stimuli responsiveness shown by controlled drug delivery systems, the 
materials that make up the drug delivery system should also be biocompatible (in order to more 
effectively resist the immune response and thus avoid being immediately cleared from the body). 
They should also present no toxic effects (either from the materials themselves or any potential 
degradation products), as well as having the requisite swelling ability to allow drugs to diffuse out 
of the material upon exposure to the stimulus. 
6.2 Useful Properties of PVA Hydrogels 
 PVA hydrogels have chemical and physical properties that make them useful for controlled 
drug delivery applications. They demonstrate sensitivity to the pH of their surroundings and show 
a change in hydrogel structure in response to a change in environmental pH [69]. This makes them 
well-suited for application in oral drug delivery, in which the PVA hydrogel would “shrivel” in 
the low pH environment of the stomach (protecting the drug from the highly degradative stomach 
acids) while “swelling” in the neutral pH environment present in the small intestine and allowing 
the drug to be absorbed into the bloodstream. While this pH-responsiveness is not as strong as that 
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of other materials such as poly(ethylene glycol) or poly(acrylic acid), PVA hydrogels are 
responsive to changes in this stimulus. 
 As mentioned before, PVA hydrogels are also biocompatible and will not trigger a very 
severe immune response when exposed to the body [70]. This is especially important with 
controlled drug delivery systems because their effectiveness is in part dependent on the amount of 
time that they are in the body – if they are cleared too quickly by the immune system, then they 
will not be able to deliver the drug at the level that it needs to be delivered. In addition, PVA itself 
is a non-toxic material, and any possible degradation products such as vinyl acetate monomers are 
generally non-toxic as well [71]. 
 Finally, PVA hydrogels demonstrate good swelling behavior upon exposure to changes in 
environmental pH. This swelling is especially present in chemically crosslinked PVA hydrogels, 
as the chemical crosslinks are more robust and do not lead to the presence of crystalline blocks 
(unlike physical crosslinking methods) [71]. However, both methods of crosslinking produce gels 
that can swell and shrink when exposed to different pH, and thus have potential applications in 
controlled drug delivery.  
6.3 Current Uses of PVA Hydrogels in Drug Delivery 
6.3.1 Pure PVA Hydrogels in Drug Delivery 
There are a few ways in which PVA hydrogels have been investigated for use in controlled 
drug delivery applications. Pure PVA hydrogels have been explored as oral drug delivery systems 
for a couple of different drugs [71]. Peppas and Mongia [72] used physical crosslinking techniques 
such as freeze-thaw cycles to prepare PVA cryogels for the delivery of smaller molecular weight 
drugs such as oxprenolol and theophylline. They examined the effect of the number of freeze-thaw 
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cycles on the release profile of these drugs from the hydrogels and found that increasing the 
number of freeze-thaw cycles led to a slower rate of drug release (probably due to the presence of 
more crystalline regions in the hydrogel structure). In addition, Kimura et al. [73] prepared PVA 
gel spheres for the delivery of insulin into the body. They used gel spheres due to their increased 
residence time in the body, which would improve the delivery of insulin over a prolonged period. 
They found that using these gel spheres resulted in successful delivery of insulin to diabetic rats 
and improved bioavailability of insulin. 
However, pure PVA hydrogels (while good biomaterials for drug delivery) are not optimal 
for this application because of their limited pH-responsiveness (in comparison to other materials 
such as polyethylene glycol or poly(acrylic acid)) and relatively small swelling ability [71]. As a 
result, researchers have increasingly focused on investigating the use of PVA-based composite 
hydrogels in order to enhance properties such as pH-response., swelling, and biocompatibility [71]. 
The next two sections will cover the applications of PVA-natural polymer composite hydrogels 
and PVA-synthetic polymer composite hydrogels in controlled drug delivery. 
6.3.2 PVA-Natural Polymer Composite Hydrogels in Drug Delivery  
 PVA-natural polymer composite hydrogels have been investigated for controlled drug 
delivery applications in order to enhance properties such as pH sensitivity and biocompatibility 
[71]. These polymers are readily available and generally do not have any effect on the cytotoxicity 
of the hydrogels, meaning that they can be incorporated cheaply without posing any new hazards 
towards the human body. A few types of natural polymers that are used in these composite 
hydrogel systems include alginate, gelatin, and silk fibroin. 
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 Alginate, as described before, is a linear polysaccharide that is generally found in seaweed 
and brown algae [48]. Alginate is generally used as a composite material in PVA-based hydrogels 
because of its biocompatibility and ability to form interpenetrating networks with PVA; these 
interpenetrating networks have improved mechanical properties, making these hydrogels more 
suitable for biomedical applications. Xie et al. [74] used freeze-thaw cycles to physically crosslink 
PVA hydrogels before using Ca2+ ions to chemically crosslink alginate chains to form an 
interpenetrating network. The resulting hydrogel showed significantly improved swelling kinetics 
and pH sensitivity as compared to normally synthesized PVA hydrogels, as well as a relationship 
between the composition of the composite hydrogel and the pH sensitivity of the hydrogel [74]. 
This result shows that a functional PVA-alginate composite hydrogel can be synthesized with 
enhanced pH sensitivity and good mechanical properties (making it suitable for controlled oral 
drug delivery). 
 Gelatin is a water-soluble protein that is generally obtained by isolation and preparation 
from collagen [71]; its major uses are in the food industry as the foundation for jelly-based 
products. Gelatin has been examined as a possible biomaterial due to its good biocompatibility and 
hydrophilicity, which makes it good for biomedical applications. Pal et al. [75] used an 
esterification reaction to create a PVA-gelatin composite hydrogel membrane and tested the effect 
of the gelatin on the mechanical properties of the hydrogel and the diffusion of salicylic acid out 
of the membrane. They found that the mechanical properties and water absorption capabilities of 
the membrane were sufficient for an implantable drug delivery system. In addition, they observed 
that the diffusion coefficient of salicylic acid through the membrane was sufficient for drug 
delivery applications [75]. They concluded that using a PVA-gelatin composite hydrogel 
membrane showed promise as an implantable drug delivery system. 
  
42 
 
 Silk fibroin is an insoluble protein that is made naturally by the Bombyx mori silkworm 
and has been used mostly as a surgical suture material [76]. Silk fibroin is being studied for 
possible biomedical applications due to its easy processability, biocompatibility, and mechanical 
strength; another advantage that makes it suitable for drug delivery applications is its stabilizing 
effect [76]. Kundu et al. [77] used photocrosslinking techniques to synthesize a PVA-silk fibroin 
composite hydrogel and tested the effects of silk fibroin on the gels’ water uptake properties and 
dextran release profiles. They found that adding silk fibroin significantly increased the water 
uptake by the gels, while increasing the amount of silk fibroin in the gels allowed for greater and 
faster drug delivery over the same period [77]. They concluded that PVA-silk fibroin composite 
hydrogels had promise in controlled drug delivery.   
6.3.3 PVA-Synthetic Polymer Composite Hydrogels in Drug Delivery 
 PVA-synthetic polymer composite hydrogels have also been developed as controlled drug 
delivery mechanisms [71]. While these polymers are not as common as the natural polymers, they 
can be tailored and functionalized to have specific properties that enhance their applications in 
drug delivery, such as enhanced stimuli-responsiveness and the ability to remain in the 
bloodstream without being removed by the immune system [71][82]. Two types of synthetic 
polymers that have been used in PVA-based composite hydrogels for controlled drug delivery 
applications are polyethylene glycol and poly(acrylic acid). 
 Polyethylene glycol (PEG) is a synthetic polymer composed of repeat ethylene oxide units 
[78]. This polymer, due to its high hydrophilicity, good biocompatibility, and pH-responsiveness, 
has been used in a variety of different biomedical applications [78]. In addition, it confers an 
additional benefit when used in controlled drug delivery systems due to its ability to inhibit a 
phenomenon known as “opsonization”, which reduces blood clearance of the drug delivery 
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systems and thus improves the efficacy of drug delivery [78][83]. Gadea et al. [79] crosslinked 
PVA hydrogels with acyl chloride-modified PEG to form a crosslinked composite hydrogel. The 
group then tested the effect of PEG addition on the swelling capabilities and pH-responsiveness of 
the hydrogels. They found that the amount of PEG added to the hydrogels affects the water 
swelling properties and produces pH-sensitivity that is especially pronounced at higher pH [79]. 
These results indicate that a PVA-PEG composite hydrogel has potential benefits as a drug 
delivery system due to enhanced stimuli-responsiveness. 
 Poly(acrylic acid) (PAA) is a synthetic polymer composed of repeat units of acrylic acid; 
this polymer is known as a polyelectrolyte because at neutral pH, the acrylic acid units will lose a 
proton to the solution and carry a negative charge [80][84]. Due to its pH-sensitivity, 
biocompatibility, and temperature-sensitivity, PAA has been studied as a potential polymeric 
material for controlled drug delivery. Shin et al. [81] synthesized interpenetrating networks 
consisting of PVA and PAA chains to create a hydrogel system. They then tested the swelling 
capabilities, pH-responsivity, and temperature-sensitivity of the newly created system. They found 
that the hydrogel could change structure in response to changes in both buffer pH and the 
temperature of the surrounding environment, and this caused changes in the release of the 
encapsulated indomethacin drug [81]. They concluded that creating a PVA-PAA interpenetrating 
network hydrogel allowed for the possibility of a drug delivery system that was sensitive to 
multiple stimuli.
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CHAPTER SEVEN 
Conclusions 
 Biomaterials exhibit potential to address a number of different issues facing the medical 
field today. These include accelerating wound healing, regeneration of tissues and tissue 
replacement, and increasing the efficacy of drugs in the body through targeted and controlled 
delivery of therapeutics. Solving these problems could result in significantly improved treatment 
of diseases and other ailments, leading to a greater overall standard of living for people.  
The development of novel biomaterials, especially the use of polymers with unique 
capabilities, has greatly improved the potential for solving these problems. One such polymer that 
has been widely investigated for use in biomedical applications is poly(vinyl alcohol). This 
polymer, which is generally synthesized by polymerizing vinyl acetate monomer and using 
transesterification to produce the final polymer, can form hydrogels through either physical 
crosslinking (which uses repeated freeze-thaw cycles to form cryogels) or chemical crosslinking 
through the use of difunctional crosslinkers such as glutaraldehyde. These hydrogels possess 
beneficial physical properties such as biocompatibility, mechanical properties and microstructure 
that closely resembles that of biological tissue, and a slight pH responsivity. 
These properties make PVA hydrogels useful in biomedical applications, including wound 
healing, tissue engineering and drug delivery. Wound healing is enhanced by materials that 
promote cell growth at the wound site and prevent harmful infections during the healing process. 
Another application of PVA-based biomaterials is in tissue engineering, in which biomaterials 
serve as scaffolds that can promote cell growth and as temporary tissue replacements; these 
scaffolds degrade over time as the tissue regenerates. A third application is in controlled drug 
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delivery, in which PVA is used as a carrier or encapsulant. Then, the encapsulated drugs are 
released in the body at controlled rates as the drug delivery systems changes structural 
characteristics in response to the imposition of a certain stimulus, e.g., pH or temperature. 
The properties of PVA hydrogels make them potential biomaterials for these applications. 
Researchers have investigated the potential for several PVA-based hydrogels for use in wound 
dressings, tissue engineering scaffolds, and controlled drug delivery systems. Pure PVA hydrogels 
have been studied as biomaterials for these applications, and the results demonstrate that these 
hydrogels have some promise. However, there are limitations in the properties of pure PVA 
hydrogels that make them less effective in these applications. To enhance the properties of PVA 
hydrogels, researchers have explored creating composite hydrogels containing both PVA and other 
materials such as natural polymers, synthetic polymers, and inorganic nanomaterials. These 
materials possess unique properties that can either complement or enhance the properties provided 
by PVA hydrogels, meaning that these composite materials can be even more effective as 
biomaterials for wound healing, tissue engineering, and controlled drug delivery. The research into 
creating composite PVA-based hydrogels with these different materials shows that the composite 
materials have enhanced properties that make them more suitable as biomaterials for these 
applications. 
In summary, poly(vinyl alcohol)-based biomaterials have shown the properties that make 
them suitable for different biomedical applications, and PVA-based materials have been 
investigated for wound healing, tissue engineering, and controlled drug delivery applications. With 
the development of composite materials that combine the properties of PVA with the properties of 
other materials, the applicability of PVA in biomedical applications is further enhanced. Future 
work will focus on determining the optimal PVA-based material for each of these applications 
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(through experimenting with other potential composite materials with unique properties) and 
comparing them to materials derived from other sources to determine whether the PVA-based 
materials provide the most effective method of treating these problems. This will hopefully result 
in the identification of the most effective materials for solving different biomedical problems. 
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